Blood Flow Measurement Devices Market Analysis & Forecast: 2025-2032

Blood Flow Measurement Devices Market Market Size and Forecast – 2025-2032

The Global Blood Flow Measurement Devices Market is estimated to be valued at USD 886.0 Mn in 2025 and is expected to reach USD 1,652.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.

Key Takeaways:

• Based on Product Type, Laser Doppler Blood Flowmeters acquired the prominent share of 35.5% in 2025 as it can be used in various medical specialties, including wound care and ophthalmology.
• On the basis of Application segment, Cardiovascular Disease dominates the overall market with an estimated share of 45.5% in 2025 owing to the aging population.
• On the basis of End-User segment, the market is bifurcated into Cardiovascular Disease, Tumor Monitoring, Gastroenterology, Diabetes, Dermatology, and others. The growing prevalence of chronic disorders are expected to drive the demand for blood flow measurement devices across these segments.
• Based on Region, North America led the overall blood flow measurement devices market growth on account of escalating research and development activities across United States and Canada.

Market Overview

The demand for blood flow measurement devices is expected to increase. Key factors driving this growth include the rising geriatric population, more cardiovascular diseases, and a growing preference for minimally invasive surgeries. Technological advancements in Doppler ultrasound systems will further improve blood flow detection and assessment, boosting market growth. However, the high cost of advanced devices may slow market growth.

Current Events and their Impact on the Blood Flow Measurement Devices Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Analysis

To learn more about this report, Request sample copy

Blood Flow Measurement Devices Market Insights, by Product Type, Laser Doppler Blood Flowmeters contribute the highest share of the market owing to its non-invasive nature and precision

Laser Doppler Blood Flowmeters have seen significant adoption in the global blood flow measurement devices market with an estimated share of 35.5% in 2025 due to their non-invasive capabilities. Unlike other product types that require probes or needles inserted into the body, Laser Doppler Flowmeters use laser beams directed at the skin to painlessly measure blood flow in small vessels just below the surface. This allows the device to monitor perfusion in several superficial tissues without any discomfort to patients. The non-invasive functionality of Laser Doppler Flowmeters makes them highly preferable for routine monitoring applications.

Medical practitioners are able to easily take repeated measurements over time to track blood flow changes in conditions like peripheral vascular disease, hypertension, and wound healing. Moreover, the growing prevalence of PAD and other circulatory conditions is also escalating the demand for these flowmeters. For instance, according to an article published by the National Library of Medicine, more than 200 million people across the globe suffers with peripheral artery disease. Laser Doppler Blood Flowmeters provide a non-invasive method to measure blood flow, especially in peripheral areas such as the legs or feet, where PAD commonly affects circulation. These factors are further positively influencing the blood flow measurement devices market share.

Blood Flow Measurement Devices Market Insights, by Application, Cardiovascular Disease drives the largest application segment due to aging populations and risk factor prevalence

Within the global blood flow measurement devices market by application, cardiovascular disease accounts for the highest usage with an estimated share of 45.5% in 2025. This predominance stems from several interrelated factors influencing disease prevalence on a global scale. Additionally, increasingly aging populations worldwide are contributing to a higher burden of cardiovascular conditions. Conditions like coronary artery disease, heart failure, and stroke have a strong correlation with advanced age. For instance, according to the Memorial Hermann Foundation, people aging 65 years or older account for roughly 80% of coronary heart disease deaths. As lifespans continue lengthening, more individuals are living long enough to develop these age-related vascular issues. Also, risk factors for cardiovascular disease such as obesity, diabetes, and hypertension are on the rise globally due to shifts in diet, activity levels and lifestyles. These metabolic and lifestyle changes over recent decades have created a pipeline of patients vulnerable to future cardiovascular events like heart attacks and strokes, further positively influencing the blood flow measurement devices market revenue.

Blood Flow Measurement Devices Market Insights, by End-User, the market is bifurcated into Cardiovascular Disease, Tumor Monitoring, Gastroenterology, Diabetes, Dermatology, and others

Blood flow measurement devices are extensively used in diagnosing and monitoring cardiovascular conditions such as coronary artery disease, stroke, and peripheral artery disease. In addition to this, devices used in tumor monitoring help assess tumor vascularization, which can be used to monitor the effectiveness of treatments like chemotherapy or radiation therapy, and detect the likelihood of metastasis. While in gastroenology, such devices help in monitoring conditions such as gastrointestinal bleeding, liver disease, and inflammatory bowel disease (IBD). Furthermore, for diabetes patients, blood flow measurement devices help in analyzing complications such as diabetic neuropathy or peripheral artery disease. The growing number of diabetic patients is positively influencing the blood flow measurement devices market forecast. For instance, according to the IDF, more than 850 million adults will have diabetes by 2050.

Role of AI (Artificial Intelligence) in the Blood Flow Measurement Devices Market

AI is transforming the blood flow measurement devices market by enhancing accuracy, speed, and predictive capabilities. For instance, in Laser Doppler Blood Flowmeters, AI algorithms help process complex data, improving the detection of microcirculatory changes. Perimed's PeriFlux 6000 system integrates AI to analyze blood flow measurements in real time, enabling clinicians to make more informed decisions in conditions like diabetic foot ulcers. Apart from this, AI also improves Fractional Flow Reserve (FFR) assessments in Intravascular Ultrasound (IVUS) devices. Philips’ UltraFlow system uses AI to enhance the precision of FFR measurements by automatically detecting coronary artery blockages, offering faster and more accurate results than manual methods.

Reimbursement Policies in the Blood Flow Measurement Devices Market

According to an article published by AMA, more than 80% of state Medicaid plans in United States now offer coverage for home or self-measured blood pressure (SMBP) monitoring devices. Among these, 25 states go further by also including clinical support services like patient education. Michigan is one of those states, where Medicaid has expanded its coverage to include both SMBP devices and related clinical services to improve cardiovascular outcomes and enhance patient access. Under Michigan's Medicaid program, beneficiaries of all ages with uncontrolled blood pressure can receive automated BP monitors, provided they meet specific criteria, such as having a history of heart disease or stroke.

Regional Insights

To learn more about this report, Request sample copy

North America Blood Flow Measurement Devices Market Trends

North America has established itself as the dominant region in the global blood flow measurement devices market. With the presence of major medical device companies and advanced healthcare infrastructure, countries like the U.S. and Canada are pioneers in adopting new technologies for disease diagnosis and treatment. Strong reimbursement programs by private and public health insurers ensure higher demand for sophisticated devices. Manufacturers in the region are continuously investing in research and development to bring innovative solutions. For instance, in June 2023, STAT Health, a digital health company based in the US, launched a 24/7 in-ear wearable designed to monitor blood flow to the head.

Asia Pacific Blood Flow Measurement Devices Market Trends

Asia Pacific region is demonstrating highest growth potential in the overall blood flow measuring devices market. Rapid economic development and government initiatives to modernize healthcare infrastructure have increased accessibility and affordability of medical devices. Rising cases of cardiovascular diseases and diabetes due to changing lifestyles is propelling demand. For instance, according to the 2023 ICMR INDIAB study, the number of people affected by diabetes in India is 101 million. Growing medical tourism also attracts patients from other countries seeking quality treatment at lower costs.

United States Blood Flow Measurement Devices Market

The growth of the market in United States is driven by the technological innovations, strategic product launches, and a heightened focus on cardiovascular health. Integration of advanced technologies, such as Artificial Intelligence (AI) and the Internet of Things (IoT), has enhanced the functionality of blood flow measurement devices. These innovations lead to improved efficiency, performance, and cost-effectiveness.  Besides this, the high incidence of cardiovascular diseases in the U.S. drives the importance of blood flow measurement devices. According to the Centers for Disease Control and Prevention (CDC), approximately 805,000 heart attacks occur annually in the United States, escalating the demand for effective diagnostic tools.

Europe Blood Flow Measurement Devices Market Trends

The market growth is Europe is driven by the surging investments in healthcare infrastructure and innovation. For instance, as part of the 2021–2027 financial framework, Poland will receive at least PLN 4.3 billion from the European Regional Development Fund to support regional healthcare initiatives. Key priorities include enhancing primary and specialist outpatient care, improving access to medical facilities, and advancing psychiatric care reform. With increased funding for healthcare facilities, there will be a stronger emphasis on equipping hospitals and clinics with advanced diagnostic tools, including blood flow measurement devices. These devices are essential for accurate diagnostics, especially in areas such as cardiovascular health and diabetes management, where early detection is crucial.

Market Report Scope

Blood Flow Measurement Devices Market Trend

Increasing Demand for Non-Invasive Diagnostic Procedures

The demand for non-invasive diagnostic procedures has been rising in the past decade. This is mainly due to increasing patient awareness of the risks and discomfort of invasive tests. Procedures like angiography or angioplasty involve inserting tubes into blood vessels through small incisions, which can cause complications such as bleeding or infection. These procedures also require hospitalization, increasing medical costs. In contrast, non-invasive blood flow measurement technologies offer reliable diagnostic information without harming the patient. For example, in September 2024, researchers from Keck School of Medicine of USC and Caltech developed a non-invasive device to assess stroke risk by monitoring brain blood flow. Using speckle contrast optical spectroscopy, it tracks blood flow changes during a breath-holding exercise, supporting blood flow measurement devices growth.

Growing Prevalence of Cardiovascular Diseases

Cardiovascular diseases are now the leading cause of death worldwide. According to the WHO and global burden of disease studies, nearly 18 million people die from cardiovascular conditions every year, making up over 30% of total global deaths. Key reasons for the rising prevalence include an aging population, increasing obesity, physical inactivity, poor diet habits, and high stress levels due to modern lifestyles. Genetic factors also contribute to the rise in cardiovascular conditions. This has increased the demand for blood flow measurement devices, particularly in developing countries where non-communicable chronic diseases were less common until recently.

Regularly checking blood flow patterns provides important information for managing heart health. As more people develop cardiovascular diseases in both developed and developing countries, due to aging and lifestyle changes, the need for tools to screen large groups of at-risk individuals has become more important. The rise in heart conditions has led to a higher demand for affordable, easy-to-use devices that help doctors and cardiologists monitor patients regularly. These devices also help detect problems early before they become serious and need intense treatment, which is propelling the blood flow measurement devices market share.

Blood Flow Measurement Devices Market Challenges: High cost of advanced blood flow measurement devices

A major challenge in the global blood flow measurement devices market is the high cost of advanced devices. Devices that offer accurate and precise measurements generally use advanced technologies like laser Doppler flowmetry, ultrasonic Doppler, and electromagnetic sensors. However, incorporating these cutting-edge technologies raises production costs significantly. As a result, these devices become unaffordable for many healthcare providers and patients, particularly in developing countries where budget constraints are a key issue for the healthcare sector.

Blood Flow Measurement Devices Market Opportunities: Integration of Blood Flow Measurement Devices with AI and IoT

One of the major opportunities for the global blood flow measurement devices market is the integration of blood flow measurement devices with technologies such as artificial intelligence (AI) and Internet of Things (IoT). AI and IoT capabilities can help address some of the current limitations of blood flow monitoring and enable new application areas. By integrating devices with AI, advanced analytics can be performed on the blood flow data to detect subtle changes indicative of underlying conditions. This can help improve accuracy and reliability of diagnoses. For instance, in October 2024, Boston Scientific launched the AVVIGO+ Multi-Modality Guidance System in India. This advanced IVUS and FFR system uses AI to enhance PCI precision, allowing physicians to assess coronary blockages and blood flow for better treatment decisions. 

Blood Flow Measurement Devices Market News

• In February 2025, Beats launched the Powerbeats Pro 2, featuring advanced heart rate monitoring with LED optical sensors that measure blood flow over 100 times per second, providing precise tracking of circulation.
• In January 2025, electronRx, digital medicine company unveiled purpleDx, a cardiopulmonary assessment which uses the iPhone camera to capture and measure blood flow around the face.
• In January 2025, Lumia Health launched a wearable that tracks blood flow to the head. The Lumia™ device is designed to help users monitor and manage symptoms such as dizziness, brain fog, fatigue, and fainting.
• In June 2023, STAT Health, a U.S.-based digital health company, has launched a 24/7 in-ear wearable that continuously monitors blood flow to the head. This compact device aims to help diagnose and manage symptoms like dizziness, brain fog, and fatigue, which are often linked to conditions such as long Covid, postural orthostatic tachycardia syndrome, and chronic fatigue syndrome.
• In May 2022, NuraLogix, a HealthTech AI company, introduced its 30-second contactless technology for measuring blood pressure and vital signs in Singapore.
• In February 2022, Philips enhanced its Lumify handheld point-of-care ultrasound with new advanced hemodynamic assessment and measurement features, allowing for real-time blood flow evaluation.
• In January 2021, NuraLogix introduced their app, Anura, which enables contactless blood pressure measurement without the need for cuffs or other wearables. Anura provides measurements of various physical, physiological, and psychological metrics, such as heart rate, stress levels, BMI, and cardiovascular disease risks, all with medical-grade accuracy.

*Definition: The Global Blood Flow Measurement Devices Market consists of medical devices used to measure blood flow in arteries and veins in various parts of the body. Some common blood flow measurement devices included in this market are doppler ultrasound systems, laser doppler devices, and electromagnetic blood flow meters. These medical devices are used by hospitals, clinics, and research institutes to detect abnormalities in blood circulation that can help diagnose cardiovascular diseases and other medical conditions.

Analyst Opinion (Expert Opinion)

• The Blood Flow Measurement Devices market is undergoing a significant transformation, primarily driven by Artificial Intelligence (AI) and changes in healthcare policies.
• AI's role in the Blood Flow Measurement Devices market is not merely an enhancement; it is a fundamental shift in how blood flow is measured, analyzed, and interpreted. With AI algorithms now integrated into systems like Laser Doppler Blood Flowmeters, the accuracy and speed of microcirculation detection have improved significantly. According to a study from Perimed, the use of AI in their PeriFlux 6000 system has enhanced real-time analysis of blood flow by up to 30%, allowing clinicians to detect microcirculatory changes more effectively in patients with conditions like diabetic foot ulcers.
• The importance of reimbursement policies in driving market growth cannot be overstated. As of 2023, more than 80% of state Medicaid plans in the U.S. cover home or self-measured blood pressure (SMBP) devices, a growing market segment with more than 20 million people using SMBP devices across the country. The inclusion of clinical support services—such as patient education—by over 25 states further signals a shift toward improving patient access to high-quality diagnostic tools.
• According to a United Nations report, Japan is expected to see over 35% of its population aged 65 or older by 2030, a demographic shift that will drive demand for portable and easy-to-use diagnostic devices tailored for elderly patients.

• By Product Type
  
  • Laser Doppler Blood Flowmeters
  • Ultrasonic Doppler Blood Flowmeters
  • Electromagnetic Blood Flowmeters 
• By Application
  
  • Cardiovascular Disease
  • Tumor Monitoring
  • Gastroenterology
  • Diabetes
  • Dermatology
  • Others
• By End User
  • Hospital
  • Clinics
  • Ambulatory Surgical Centers
  • Specialty Centers
  • Others
•  Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
• • Cook Medical Inc.
  • Medistim ASA
  • Transonic Systems Inc.
  • Deltex Medical Group PLC
  • Atys Medical
  • Getinge Group
  • Perimed AB
  • Compumedics
  • ADInstruments
  • Moor Instruments Ltd.
  • SONOTEC GmbH
  • ArjoHuntleigh Inc.
  • Cheetah Medical
  • Biopac Systems Inc.
  • D.E. Hokie & Associates
  • NDS Surgical Imaging
  • Fluke Biomedical
  • Koven Technology
  • GSI Group
  • Nihon Kohden Corporation

Sources

Primary Research Interviews from the following stakeholders:

Stakeholders:

• Interviews with medical professionals, device manufacturers, healthcare providers, and industry experts specializing in blood flow measurement and related technologies.
• Specific stakeholders: Cardiologists, vascular surgeons, biomedical engineers, and healthcare managers involved in diagnostic tools.

Databases:

• PubMed
• ClinicalTrials.gov
• HealthData.gov

Magazines:

• MedTech Insight
• Healthcare Technology News
• Medical Device and Diagnostic Industry (MD+DI)
• HealthTech Magazine

Journals:

• Journal of Vascular Surgery
• Journal of Medical Devices
• Biomed Optics Express
• Journal of Clinical Monitoring and Computing

Newspapers:

• The New York Times
• The Guardian
• The Wall Street Journal
• Financial Times
• The Washington Post

Associations:

• American Heart Association (AHA)
• European Society of Cardiology (ESC)
• Medical Device Manufacturers Association (MDMA)
• International Society for Vascular Surgery (ISVS)
• International Society for Research on Vascular Disease (ISRVD)

Public Domain Sources:

• World Health Organization (WHO)
• Centers for Disease Control and Prevention (CDC)
• Food and Drug Administration (FDA)
• National Institutes of Health (NIH)

Proprietary Elements:

• CMI Data Analytics Tool, and Proprietary CMI Existing Repository of information for last 8 years